Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

NEXGEL, INC.

CIK 1468929 NXGL·Medical Instruments · All EDGAR filings ↗

Progression

  1. Finance chief departure 8-K
  2. Late filing NT 10-Q +109d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Late filing Filing comparison

NEXGEL, INC. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. 3 days past the statutory due date.

Management anticipates the filing of its Quarterly Report within the applicable 5-day extension period provided.
Evidence
Anticipates significant change
No
Days past due date
3
Routine
Yes
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
Management anticipates the filing of its Quarterly Report within the applicable 5-day extension period provided.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Finance chief departure elevated Filing comparison

NEXGEL, INC.'s Chief Financial Officer departed, replaced on an interim basis

Evidence
Interim only
Yes
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
elevated
Source
SEC 8-K item code
Successor named
No
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.

Source filing ↗